Sahmri

What Sahmri does

SAHMRI (South Australian Health and Medical Research Institute Limited) is South Australia's flagship not-for-profit health and medical research institute, incorporated as a company limited by guarantee in South Australia and headquartered on North Terrace, Adelaide. The institute employs 700+ researchers and operates four major research themes — Aboriginal Health Equity (Wardliparingga), Lifelong Health, Precision Cancer Medicine, and Women and Kids — alongside specialized platforms including the Clinical & Research Imaging Centre (CRIC), the Preclinical, Imaging and Research Laboratories (PIRL), the Molecular Imaging and Therapy Research Unit (MITRU), the South Australian Genomics Centre (SAGC), Brain Organoid Therapeutics (BOT), and the Clinical Trials Platform supporting 46+ projects with 35+ researchers. SAHMRI also operates the Registry of Senior Australians (ROSA) Research Centre, a national multisectoral integrated data platform monitoring health, medication use, and mortality outcomes for over 3.85 million Australians who accessed aged care services since 2002.

SAHMRI's core technology stack spans advanced imaging, genomics, registry data science, radiopharmaceutical manufacturing, and clinical research capabilities. MITRU houses South Australia's only cyclotron nuclear particle accelerator, producing radioactive isotopes for PET and CT scans; the facility commenced licensed production in 2015 and has delivered over 100,000 patient doses cumulatively, with 13,000+ doses produced annually. Core facilities include Bioresources, Small Animal Imaging, Cryogenics, Histology, and Flow Cytometry. The Australian Bragg Centre for Proton Therapy and Research adds specialized oncology treatment capability.

The institute's revenue model is multi-stream: competitive research grants from federal bodies including the National Health and Medical Research Council (NHMRC) and Medical Research Future Fund (MRFF), donations and philanthropic support via the Discovery Circle, Heart Appeal, and bequest programs, clinical services revenue from MITRU's radiopharmaceutical supply to South Australian hospitals and imaging providers, and partnership contributions from three founding South Australian universities (University of Adelaide, University of South Australia, Flinders University) plus state and federal government partners. SAHMRI does not sell commercial products and research participation is voluntary. The organization has produced 21,000+ publications and contributed to globally adopted treatments including tyrosine kinase inhibitors for chronic myeloid leukaemia.

Name

Sahmri

Legal name

South Australian Health and Medical Research Institute Limited

Website

https://sahmri.org.au

Company type

Private

Operating status

Operating

Short description

SAHMRI is South Australia's flagship not-for-profit health and medical research institute, employing 700+ researchers across four major themes (Aboriginal Health Equity, Lifelong Health, Precision Cancer Medicine, Women and Kids) and operating specialized platforms including the state's only cyclotron for radiopharmaceuticals and the national ROSA aged care registry covering 3.85 million Australians.

Ownership category

akta.pro rank

Product category

Medical Research Services

NAICS

Scientific Research and Development Services (5417), Research and Development in the Physical, Engineering, and Life Sciences (54171), Research and Development in Biotechnology (except Nanobiotechnology) (541714), Medical and Diagnostic Laboratories (6215)

SIC

Services-Commercial Physical & Biological Research (8731), Services-Medical Laboratories (8071), In Vitro & In Vivo Diagnostic Substances (2835)

akta.pro industry

PRIMARYHLAGACAG

Clinical Trial Monitoring Support (On-site/Remote)

Healthcare & Life Sciences/Life Science Tools & Services (CRO/CDMO/Lab Services)/Clinical Trial Services & Site Management (SMO)

SECONDARYHLAFAMAL

Clinical Research & Trial Central Laboratories

Healthcare & Life Sciences/Healthcare Providers & Systems/Clinical Laboratories

SECONDARYHLAGAEAD

Genomics & Molecular Diagnostics (Trial Support)

Healthcare & Life Sciences/Life Science Tools & Services (CRO/CDMO/Lab Services)/Central Labs & Clinical Diagnostics Services (Trial Support)

SECONDARYHLAGAJAM

Clinical Trial Informatics (EDC/CTMS/eCOA/eTMF)

Healthcare & Life Sciences/Life Science Tools & Services (CRO/CDMO/Lab Services)/Life Science Software & Informatics (LIMS/ELN/Bioinformatics)

Keywords

• Medical research institute
• Clinical trials research
• Radiopharmaceutical manufacturing
• Health data registry
• Biomedical imaging

Headquarters

HQ city

Adelaide

HQ country

Australia

HQ region

Oceania

Offices1 record

Markets served

GTM type

B2B

Offering type

Services

Cost components

Personnel, Technology or R&D, Operations, Infrastructure, Marketing or Sales

Revenue model

1. Research Grants and Government Funding: SAHMRI receives funding through competitive research grants from bodies such as NHMRC, MRFF, and government agencies to support its research programs and clinical trials.
2. Donations and Philanthropic Support: The institute receives donations through various programs including Discovery Circle, direct donations, bequests, and memorial giving. SAHMRI conducts fundraising campaigns such as the Heart Appeal.
3. Clinical Services Revenue: MITRU generates revenue by supplying radiopharmaceuticals to hospitals and imaging providers across South Australia, with over 13,000 doses produced annually.
4. Partnership Contributions: University partners (University of Adelaide, University of South Australia, Flinders University) and government partners contribute to joint research initiatives and operational support.

Go-to-market motion1 record

Distribution channels3 records

Marketing channels7 records

Core offering

SAHMRI is South Australia's flagship not-for-profit health and medical research institute that conducts translational medical research across four themes (Aboriginal Health Equity, Lifelong Health, Precision Cancer Medicine, and Women and Kids). It operates advanced research platforms including the MITRU cyclotron for radiopharmaceutical production, the ROSA national aged care data registry, clinical and research imaging centres, genomics, clinical trials, and the Australian Bragg Centre for Proton Therapy, delivering research outputs, diagnostic products, and data services to hospitals, universities, and government partners.

Product overview

SAHMRI is a not-for-profit health and medical research institute operating as a platform of specialized research centers and services rather than a single commercial product. The institute comprises four major research themes (Aboriginal Health Equity, Lifelong Health, Precision Cancer Medicine, Women and Kids), multiple research platforms (CRIC, MITRU, PIRL, Clinical Trials Platform, SAGC), core facilities (Bioresources, Small Animal Imaging, Cryogenics, Histology, Flow Cytometry), and specialized centers (ROSA Research Centre, Hopwood Centre for Neurobiology, Wellbeing and Resilience Centre). The 700+ researchers conduct 800+ projects and have produced 21,000+ publications, focusing on translating medical research into improved health outcomes.

Differentiator

Problem solved

Functional benefit

Brands

• Registry of Senior Australians (ROSA): National multisectoral integrated data platform monitoring health, service use, social welfare, medication use, and outcomes of people accessing aged care services.
• Clinical & Research Imaging Centre (CRIC)
• PIRL (Preclinical, Imaging and Research Laboratories)
• MITRU (Molecular Imaging and Therapy Research Unit)
• Brain Organoid Therapeutics (BOT)
• ROSA Research Centre
• SAHMRI Wellbeing and Resilience Centre
• Hopwood Centre for Neurobiology

Products and services

• Molecular Imaging and Therapy Research Unit (MITRU) Produces radiopharmaceuticals using South Australia's only cyclotron for PET/CT diagnostic imaging, supplying hospitals and imaging providers across South Australia with over 100,000 patient doses delivered since 2015 and 13,000+ doses produced annually.
• Clinical & Research Imaging Centre (CRIC) Advanced clinical and research imaging facility providing diagnostic imaging services and research imaging capabilities for SAHMRI's research programs and clinical trials.
• PIRL (Preclinical, Imaging and Research Laboratories) Preclinical imaging and research laboratory services supporting translational medical research across SAHMRI's research themes.
• Clinical Trials Platform Conducts clinical research where community volunteers participate in evaluating new diagnostic tests and treatments, supporting 46+ active projects with 35+ researchers across all four research themes.
• South Australian Genomics Centre (SAGC) Genomics research facility providing sequencing and analysis services to SAHMRI's research community and external collaborators.
• ROSA (Registry of Senior Australians) Research Centre National multisectoral integrated data platform monitoring health, service use, social welfare, medication use, and outcomes of 3.85 million Australians receiving aged care services since 2002.
• Hopwood Centre for Neurobiology Research program focused on identifying causes of major neurological disorders including Alzheimer's, Parkinson's, stroke, epilepsy, depression, spinal cord injury, and chronic pain, using neuroimaging, lifestyle interventions, novel pharmaceuticals, and stem-cell based regenerative medicine.
• SAHMRI Wellbeing and Resilience Centre Leads, measures and builds wellbeing across the life course, coordinates wellbeing initiatives, and conducts public lectures and events within SAHMRI's Mind & Brain Theme.
• Core Facilities (Bioresources, Small Animal Imaging, Cryogenics, Histology, Flow Cytometry) Shared research infrastructure providing biological resources, small animal imaging, cryogenic storage, tissue processing, and cell sorting services to SAHMRI researchers and collaborators.
• Australian Bragg Centre for Proton Therapy and Research Proton therapy facility for cancer treatment and research, providing advanced particle therapy for cancer patients in South Australia.
• Research Themes (Aboriginal Health Equity, Lifelong Health, Precision Cancer Medicine, Women and Kids) Four major research themes addressing Indigenous health research, chronic diseases across the lifespan, targeted cancer treatments, and early childhood development from conception through the first 1000 days of life.

Quantifiable outcome

• 100,000+ patient doses of radiopharmaceuticals supplied from South Australia's cyclotron
• +3 more outcomes

Named customers3 records

Segments5 records

Ideal customer profiles4 records

Technology focussed No

API detail

Has API

No

API docs

API detail

Core technology

AI maturity

App detail

Feature5 records

Partnerships

20 partnerships are on record, tiered core and major.

• Aboriginal Health Council of South Australia (AHCSA)coreStrategic or Co-development Partner · 17 June 2026Signatory to the 2026 South Australian Aboriginal Health Research Accord. AHCSA CEO Tanya McGregor signed the refreshed accord for culturally appropriate, community-led research.
• SA HealthcoreStrategic or Co-development Partner · 17 June 2026Signatory to the 2026 Aboriginal Health Research Accord. Minister for Health and Wellbeing Blair Boyer MP signed on behalf of SA Health.
• Heart FoundationmajorStrategic or Co-development Partner · 17 June 2026Signatory to the 2026 Aboriginal Health Research Accord. Represented by Dr Marie Ludlow, National Manager Regional Affairs.
• The Hospital Research Foundation Group (THRF)majorStrategic or Co-development Partner · 17 June 2026Signatory to the 2026 Aboriginal Health Research Accord. THRF supports health and medical research in South Australia.
• Adelaide Primary Health Network (APHN)majorStrategic or Co-development Partner · 17 June 2026Signatory to the 2026 Aboriginal Health Research Accord focused on primary healthcare improvement.
• Health Translation SA (HTSA)majorStrategic or Co-development Partner · 17 June 2026Signatory to the 2026 Aboriginal Health Research Accord. HTSA supports health research translation in South Australia.
• South Australian Aboriginal Community Controlled Organisation Network (SAACCON)coreStrategic or Co-development Partner · 17 June 2026Signatory to the 2026 Aboriginal Health Research Accord. Represented by Scott Wilson, Lead Convenor.
• SilverchaincoreStrategic or Co-development Partner · 1 January 2017ROSA founding partner. Silver Chain is an aged care provider collaborating on the registry's monitoring of health outcomes for older Australians.
• ECH InccoreStrategic or Co-development Partner · 1 January 2017ROSA founding partner. ECH Inc is an aged care provider contributing to the registry's integrated data platform.
• Bolton ClarkecoreStrategic or Co-development Partner · 1 January 2017ROSA founding partner. Bolton Clarke is an aged care and health services provider collaborating on research.
• SA NT DatalinkcoreStrategic or Co-development Partner · 1 January 2017ROSA founding partner providing data linkage services for the registry's national data integration platform.
• Council on the Ageing (COTA) SAcoreStrategic or Co-development Partner · 1 January 2017ROSA founding partner representing older Australians and contributing consumer perspectives to aged care research.
• University of AdelaidecoreStrategic or Co-development PartnerMajor research partnership with one of SAHMRI's three founding universities. Collaborates on various research programs including CML research led by Prof Tim Hughes.
• University of South AustraliacoreStrategic or Co-development PartnerResearch partnership with one of SAHMRI's three founding universities. Collaborates on aged care research through ROSA and other programs.
• Flinders UniversitycoreStrategic or Co-development PartnerResearch partnership with one of SAHMRI's three founding universities. Collaborates on visceral pain research (Prof Brierley), aged care research, and other programs.
• Government of South AustraliacoreStrategic or Co-development PartnerGovernment partner providing operational support and collaboration on state health initiatives. Minister for Health and Wellbeing Blair Boyer has signed the 2026 Aboriginal Health Research Accord.
• Australian GovernmentcoreStrategic or Co-development PartnerFederal government funding through NHMRC, MRFF and other agencies. Collaborates on national health research priorities.
• Cancer Council SAcoreStrategic or Co-development PartnerLong-standing partnership supporting cancer research. Cancer Council SA has partnered with SAHMRI through the Beat Cancer Project.
• Caring Futures Institute, Flinders UniversitycoreStrategic or Co-development PartnerAcademic partnership supporting ROSA Research Centre through the College of Nursing and Health Sciences at Flinders University.
• Be Well ComajorStrategic or Co-development PartnerCollaboration on mental health and wellbeing programs including the 'Be Well Plan' adapted for cancer survivors and first responders (PEREI program).

Scale indicators7 records

Recent moves9 records

Expansion highlights6 records

Direct peers

• Telethon Kids Institute: Perth-based child health research institute with comparable Aboriginal and Torres Strait Islander child health research, early life development focus, and university/health system partnership model. Comparable peer for SAHMRI's Women and Kids and Aboriginal Health Equity themes.
• Murdoch Children's Research Institute (MCRI): Large pediatric medical research institute in Melbourne affiliated with the Royal Children's Hospital. Comparable in headcount scale, translational research focus, and clinical trials platform. Particularly relevant as a peer for SAHMRI's Women and Kids Theme and pediatric clinical research output.
• Harry Perkins Institute of Medical Research: Perth-based medical research institute with comparable cancer, diabetes, and genomic medicine themes. Similar mid-sized independent medical research institute competing for NHMRC funding with multi-theme research structure.
• Victor Chang Cardiac Research Institute: Sydney-based heart and cardiovascular research institute. Relevant as a peer for SAHMRI's heart disease and cardiovascular research within the Lifelong Health Theme, with similar not-for-profit, government-grant-funded research model.
• Peter MacCallum Cancer Centre: Melbourne-based specialist cancer hospital and research center with extensive clinical trials and translational oncology programs. Directly comparable to SAHMRI's Precision Cancer Medicine Theme for cancer clinical trials and translational research capacity.
• QIMR Berghofer Medical Research Institute: Brisbane-based medical research institute with comparable cancer, infectious disease, and chronic disease research themes. Similar translational research focus, clinical trial portfolio, and government grant funding model, making it a relevant Australian peer.
• Garvan Institute of Medical Research: Sydney-based independent medical research institute with a comparable research theme structure including genomics, cancer, and metabolic disease. Operates similar core facilities and is a direct competitor for NHMRC funding and research talent in Australia.
• Walter and Eliza Hall Institute of Medical Research (WEHI): Australia's oldest medical research institute, based in Melbourne, with a comparable scale of researchers, themes in cancer and chronic disease, and a similar not-for-profit model. Directly comparable as a flagship Australian independent biomedical research institute competing for the same NHMRC/MRFF grant pools.
• Baker Heart and Diabetes Institute: Melbourne-based independent medical research institute focused on cardiovascular and metabolic disease. Comparable as a peer for SAHMRI's Lifelong Health Theme, with similar funding mix (grants, philanthropy, clinical translation) and competitive grant profile.
• Florey Institute of Neuroscience and Mental Health: Melbourne-based neuroscience and mental health research institute. Highly relevant as a peer for SAHMRI's Hopwood Centre for Neurobiology, Mind and Brain theme, and chronic pain/mental health research, with similar academic hospital partnership model.

Market position

Strengths5 records

Weaknesses5 records

Competitive moat6 records

Key risks5 records

Key highlights1 record

Customer concentration

• YouTubeyoutube.com/channel/UC5UZqJv1t1GjP9dAfOCWXXg

Revenue estimate

Valuation estimate

Number of profiles

Profiles11 records

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Sahmri